Horizon Therapeutics: Q1 Earnings Insights
Horizon Therapeutics NASDAQ:HZNP reported its Q1 earnings results on
Here's what investors need to know about the announcement.
Earnings
Horizon Therapeutics beat estimated earnings by 11.67%, reporting an EPS of
Revenue was up
Past Earnings Performance
Last quarter the company beat on EPS by
Here's a look at Horizon Therapeutics's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | 1.34 | 1.54 | 0.88 | 0.04 |
EPS Actual | 1.41 | 1.75 | 1.62 | 0.03 |
Revenue Estimate | 995.87M | 979.41M | 685.03M | 330.73M |
Revenue Actual | 1.01B | 1.04B | 832.55M | 342.41M |
To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.